Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Aug 31, 2025 | FY 2024Aug 31, 2024 | FY 2023Aug 31, 2023 | FY 2022Aug 31, 2022 | FY 2021Aug 31, 2021 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 3.2M | 2.3M | 2.4M | 3.5M | -- |
| General And Administrative Expense | 2.7M | 1.7M | 1.9M | 2.7M | -- |
| Other Operating Expenses | 55,476 | 70,735 | 64,336 | 99,532 | -- |
| Operating Expense | 3.3M | 2.3M | 2.5M | 3.6M | -- |
| Operating Income | -3.3M | -2.3M | -2.5M | -3.6M | -- |
| EBIT | -3.3M | -2.3M | -2.5M | -3.6M | -- |
| Interest Income | 228,207 | 134,990 | 83,331 | 75,619 | -- |
| Interest Income Non Operating | 228,207 | 134,990 | 83,331 | 75,619 | -- |
| Net Interest Income | 228,207 | 134,990 | 83,331 | 75,619 | -- |
| Other Income Expense | 137,534 | -93,192 | 1.5M | -312,309 | -- |
| Other Non Operating Income Expenses | 227,328 | -- | -- | -- | -- |
| Special Income Charges | -- | 0.00 | 1.6M | 0.00 | -3.1M |
| Gain On Sale Of Security | -89,794 | -93,192 | -130,829 | -312,309 | -- |
| Pretax Income | -2.9M | -2.3M | -927,272 | -3.8M | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -2.9M | -2.3M | -927,272 | -3.8M | -- |
| Net Income From Continuing Operation Net Minority Interest | -2.9M | -2.3M | -927,272 | -3.8M | -- |
| Net Income Including Noncontrolling Interests | -2.9M | -2.3M | -927,272 | -3.8M | -- |
| Net Income Common Stockholders | -2.9M | -2.3M | -927,272 | -3.8M | -- |
| Net Income | -2.9M | -2.3M | -927,272 | -3.8M | -- |
| EBITDA | -3.3M | -2.3M | -2.5M | -3.6M | -- |
| Normalized EBITDA | -3.2M | -2.2M | -4.0M | -3.3M | -- |
| Reconciled Depreciation | 9,292 | 8,587 | 439.00 | 404.00 | -- |
| Basic EPS | 0.03 | 0.04 | -0.02 | -15.21 | -- |
| Diluted EPS | 0.03 | 0.04 | -0.02 | -15.21 | -- |
| Basic Average Shares | 84.5M | 60.1M | 48.1M | 257,640 | -- |
| Diluted Average Shares | 84.5M | 60.1M | 48.1M | 257,640 | -- |
| Total Unusual Items | -89,794 | -93,192 | 1.5M | -312,309 | -- |
| Total Unusual Items Excluding Goodwill | -89,794 | -93,192 | 1.5M | -312,309 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -2.8M | -2.2M | -2.4M | -3.5M | -- |
| Diluted NI Availto Com Stockholders | -2.9M | -2.3M | -927,272 | -3.8M | -- |
| Gain On Sale Of Ppe | -- | 0.00 | 1.6M | 0.00 | 0.00 |
| Impairment Of Capital Assets | -- | -- | -- | 0.00 | 3.1M |
| Net Income Continuous Operations | -2.9M | -2.3M | -927,272 | -3.8M | -- |
| Net Non Operating Interest Income Expense | 228,207 | 134,990 | 83,331 | 75,619 | -- |
| Other Gand A | 2.0M | 1.5M | 1.5M | 1.9M | -- |
| Salaries And Wages | 735,233 | 157,726 | 432,476 | 816,125 | -- |
| Selling And Marketing Expense | 485,651 | 612,664 | 518,908 | 741,458 | -- |
| Total Expenses | 3.3M | 2.3M | 2.5M | 3.6M | -- |
| Line Item | FY 2025Aug 31, 2025 | FY 2024Aug 31, 2024 | FY 2023Aug 31, 2023 | FY 2022Aug 31, 2022 | FY 2021Aug 31, 2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 11.9M | 1.5M | 2.8M | 7.3M | -- |
| Cash Cash Equivalents And Short Term Investments | 11.9M | 1.6M | 2.9M | 7.6M | -- |
| Other Short Term Investments | 21,875 | 31,250 | 53,125 | 326,536 | -- |
| Accounts Receivable | 17,409 | 16,860 | -- | -- | -- |
| Receivables | 17,409 | 16,860 | 37,618 | 171,027 | -- |
| Prepaid Assets | 268,105 | 98,801 | 154,646 | 425,889 | -- |
| Current Assets | 12.2M | 1.7M | 3.1M | 8.3M | -- |
| Gross PPE | 63.4M | 58.4M | 51.8M | 41.4M | -- |
| Accumulated Depreciation | -154,091 | -125,608 | -134,447 | -105,190 | -- |
| Net PPE | 63.3M | 58.3M | 51.6M | 41.3M | -- |
| Total Non Current Assets | 63.3M | 58.3M | 52.2M | 41.3M | -- |
| Total Assets | 75.5M | 60.1M | 55.3M | 49.5M | -- |
| Accounts Payable | 534,033 | 325,208 | -- | -- | -- |
| Payables | 569,811 | 365,038 | -- | -- | -- |
| Payables And Accrued Expenses | 569,811 | 365,038 | 482,146 | 1.0M | -- |
| Current Deferred Revenue | 654,858 | 0.00 | -- | -- | -- |
| Current Liabilities | 1.2M | 365,038 | 482,146 | 1.0M | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 1.2M | 365,038 | 482,146 | 1.0M | -- |
| Common Stock | 90.2M | 75.3M | 67.4M | 62.6M | -- |
| Capital Stock | 90.2M | 75.3M | 67.4M | 62.6M | -- |
| Additional Paid In Capital | 7.1M | 6.2M | 5.9M | 5.3M | -- |
| Retained Earnings | -25.6M | -22.7M | -20.4M | -19.5M | -- |
| Gains Losses Not Affecting Retained Earnings | 2.5M | 882,295 | 1.9M | 84,005 | -- |
| Other Equity Adjustments | 2.5M | 882,295 | 1.9M | 84,005 | -- |
| Common Stock Equity | 74.3M | 59.7M | 54.9M | 48.5M | -- |
| Stockholders Equity | 74.3M | 59.7M | 54.9M | 48.5M | -- |
| Total Equity Gross Minority Interest | 74.3M | 59.7M | 54.9M | 48.5M | -- |
| Total Capitalization | 74.3M | 59.7M | 54.9M | 48.5M | -- |
| Net Tangible Assets | 74.3M | 59.7M | 54.9M | 48.5M | -- |
| Tangible Book Value | 74.3M | 59.7M | 54.9M | 48.5M | -- |
| Working Capital | 11.0M | 1.4M | 2.6M | 7.3M | -- |
| Invested Capital | 74.3M | 59.7M | 54.9M | 48.5M | -- |
| Share Issued | 99.9M | 61.9M | 53.0M | 45.3M | -- |
| Ordinary Shares Number | 99.9M | 61.9M | 53.0M | 45.3M | -- |
| Current Deferred Liabilities | 654,858 | 0.00 | -- | -- | -- |
| Machinery Furniture Equipment | 213,947 | 207,936 | 241,891 | 180,631 | -- |
| Non Current Deferred Assets | -- | -- | -- | 23.4M | 10.4M |
| Non Current Prepaid Assets | 43,030 | 26,094 | 573,836 | 0.00 | -- |
| Other Equity Interest | -- | -- | -- | 66,390 | 66,390 |
| Other Payable | 35,778 | 39,830 | -- | -- | -- |
| Other Properties | 63.2M | 58.2M | 51.5M | 41.2M | -- |
| Restricted Cash | 52,069 | 50,790 | 50,788 | 50,790 | -- |
| Taxes Receivable | -- | 16,860 | 37,618 | 171,027 | 35,701 |
| Line Item | FY 2025Aug 31, 2025 | FY 2024Aug 31, 2024 | FY 2023Aug 31, 2023 | FY 2022Aug 31, 2022 | FY 2021Aug 31, 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | -2.4M | -2.4M | -2.6M | -3.8M | -- |
| Cash Flow From Continuing Operating Activities | -2.4M | -2.4M | -2.6M | -3.8M | -- |
| Depreciation And Amortization | 9,292 | 8,587 | 439.00 | 404.00 | -- |
| Depreciation Amortization Depletion | 9,292 | 8,587 | 439.00 | 404.00 | -- |
| Stock Based Compensation | 735,233 | 157,726 | 432,476 | 816,125 | -- |
| Change In Working Capital | -256,728 | -242,114 | -557,356 | -1.0M | -- |
| Change In Receivables | -549.00 | 24,183 | 58,409 | -60,326 | -- |
| Change In Payables And Accrued Expense | -86,875 | -322,142 | -887,008 | -739,577 | -- |
| Other Non Cash Items | -1,443 | -1,261 | -1,253 | -714.00 | -- |
| Capital Expenditure | -3.0M | -6.8M | -8.7M | -13.1M | -- |
| Purchase Of PPE | -3.0M | -6.8M | -8.2M | -13.1M | -- |
| Net PPE Purchase And Sale | -3.0M | -6.8M | -8.2M | -13.1M | -- |
| Sale Of Investment | -- | 0.00 | 271,211 | 26,970 | 816,381 |
| Net Investment Purchase And Sale | -- | 0.00 | 271,211 | 26,970 | 816,381 |
| Investing Cash Flow | -2.4M | -6.8M | -6.8M | -13.1M | -- |
| Cash Flow From Continuing Investing Activities | -2.4M | -6.8M | -6.8M | -13.1M | -- |
| Issuance Of Capital Stock | 15.2M | 8.1M | 5.0M | 19.3M | -- |
| Net Common Stock Issuance | 15.2M | 8.1M | 5.0M | 19.3M | -- |
| Financing Cash Flow | 14.9M | 7.8M | 4.9M | 18.0M | -- |
| Cash Flow From Continuing Financing Activities | 14.9M | 7.8M | 4.9M | 18.0M | -- |
| Effect Of Exchange Rate Changes | 144,938 | -16,710 | 113,191 | 351,553 | -- |
| Changes In Cash | 10.2M | -1.3M | -4.6M | 1.1M | -- |
| Beginning Cash Position | 1.5M | 2.8M | 7.3M | 5.8M | -- |
| End Cash Position | 11.9M | 1.5M | 2.8M | 7.3M | -- |
| Free Cash Flow | -5.4M | -9.2M | -11.3M | -16.9M | -- |
| Asset Impairment Charge | -- | -- | -- | 0.00 | 3.1M |
| Capital Expenditure Reported | -- | 0.00 | -573,836 | 0.00 | -- |
| Change In Prepaid Assets | -169,304 | 55,845 | 271,243 | -210,818 | -- |
| Common Stock Issuance | 15.2M | 8.1M | 5.0M | 19.3M | -- |
| Depreciation | 9,292 | 8,587 | 439.00 | 404.00 | -- |
| Gain Loss On Investment Securities | 9,375 | 21,875 | 77,200 | 224,297 | -- |
| Gain Loss On Sale Of PPE | 0.00 | -3,681 | -1.6M | 0.00 | -- |
| Interest Received Cfo | 164.00 | 1,259 | 1,255 | 0.00 | -- |
| Net Income From Continuing Operations | -2.9M | -2.3M | -927,272 | -3.8M | -- |
| Net Intangibles Purchase And Sale | -- | 0.00 | 1.6M | 0.00 | -- |
| Net Other Financing Charges | -297,142 | -201,177 | -134,808 | -1.3M | -- |
| Net Other Investing Changes | 637,992 | -- | -573,836 | -13.1M | -5.5M |
| Operating Gains Losses | 9,375 | 18,194 | -1.5M | 224,297 | -- |
| Proceeds From Stock Option Exercised | -- | -- | 0.00 | 21,189 | 2.8M |
| Sale Of Intangibles | -- | 0.00 | 1.6M | 0.00 | -- |
| Sale Of PPE | 0.00 | 22,891 | 0.00 | -- | -- |
| Unrealized Gain Loss On Investment Securities | -- | -- | -- | -- | -95,570 |